Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.

Journal of the American Geriatrics Society - 1 Oct 1997

Arai H, Terajima M, Miura M, Higuchi S, Muramatsu T, Matsushita S, Machida N, Nakagawa T, Lee V M, Trojanowski J Q, Sasaki H

Abstract excerpt

OBJECTIVE: This study was undertaken to gain insights into the clinical utility of measuring cerebrospinal fluid tau protein (CSF-tau) to aid in the diagnosis of Alzheimer's disease (AD). SETTING: AD patients from Tohoku University Hospital, Sendai Japan were sampled. SUBJECTS AND METHODS: CSF-tau levels were examined by sandwich enzyme-linked immunosorbent assay in a total of 62 patients carrying different alpha...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Apolipoproteins E

Share to Genotype

Share to Membrane Proteins

Share to Risk Factors

Share to Time Factors

Source

Identifiers

PMID: 9329486
DOI: 10.1111/j.1532-5415.1997.tb03775.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of genetic risk factors and disease progression on the cerebrospinal fluid tau levels in Alzheimer's disease.PMID 9329486Read ↗

Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease.Semantic proximity Read ↗

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.Semantic proximity Read ↗

High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson disease.Semantic proximity Read ↗

The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.Semantic proximity Read ↗

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.Semantic proximity Read ↗

CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity.Semantic proximity Read ↗

Longitudinal stability of CSF tau levels in Alzheimer patients.Semantic proximity Read ↗

Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.Semantic proximity Read ↗

Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.Semantic proximity Read ↗

CSF tau is related to apolipoprotein E genotype in early Alzheimer's disease.Semantic proximity Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Cerebrospinal Fluid Biomarkers in Familial Forms of Alzheimer's Disease and Frontotemporal Dementia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.